Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association.
international consensus
radiofrequency ablation
thermal ablation
thyroid ablation
ultrasound-guided ablation
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
01
12
2021
accepted:
02
12
2021
pubmed:
24
12
2021
medline:
17
3
2022
entrez:
23
12
2021
Statut:
ppublish
Résumé
The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. This document has been developed as an international interdisciplinary evidence-based statement with a primary focus on radiofrequency ablation and is intended to serve as a manual for best practice application of ablation technologies. A comprehensive literature review was conducted to guide statement development and generation of best practice recommendations. Modified Delphi method was applied to assess whether statements met consensus among the entire author panel. A review of the current state of ultrasound-guided ablation procedures for the treatment of benign and malignant thyroid conditions is presented. Eighteen best practice recommendations in topic areas of preprocedural evaluation, technique, postprocedural management, efficacy, potential complications, and implementation are provided. As ultrasound-guided ablation procedures are increasingly utilized in benign and malignant thyroid disease, evidence-based and thoughtful application of best practices is warranted.
Sections du résumé
BACKGROUND
The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. This document has been developed as an international interdisciplinary evidence-based statement with a primary focus on radiofrequency ablation and is intended to serve as a manual for best practice application of ablation technologies.
METHODS
A comprehensive literature review was conducted to guide statement development and generation of best practice recommendations. Modified Delphi method was applied to assess whether statements met consensus among the entire author panel.
RESULTS
A review of the current state of ultrasound-guided ablation procedures for the treatment of benign and malignant thyroid conditions is presented. Eighteen best practice recommendations in topic areas of preprocedural evaluation, technique, postprocedural management, efficacy, potential complications, and implementation are provided.
CONCLUSIONS
As ultrasound-guided ablation procedures are increasingly utilized in benign and malignant thyroid disease, evidence-based and thoughtful application of best practices is warranted.
Types de publication
Consensus Development Conference
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
633-660Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Hahn SY, Shin JH, Na DG, et al. Ethanol ablation of the thyroid nodules: 2018 consensus statement by the Korean society of thyroid radiology. Korean J Radiol. 2019;20:609-620. doi:10.3348/kjr.2018.0696
Kim J-H, Baek JH, Lim HK, et al. Thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2017;19(4):632-655. doi:10.3348/kjr.2018.19.4.632
Papini E, Monpeyssen H, Frasoldati A, Hegedüs L. European thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J. 2020;9(4):172-185. doi:10.1159/000508484
Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36(1):376-382. doi:10.1080/02656736.2019.1575482
Dobnig H, Zechmann W, Hermann M, et al. Radiofrequency ablation of thyroid nodules: “good clinical practice recommendations” for Austria: an interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH). Wien Med Wochenschr. 2020;170:6-14. doi:10.1007/s10354-019-0682-2
Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29:611-618. doi:10.1089/thy.2018.0604
Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumorablation: standardization ofterminology and reporting criteria-a 10-year update. J Vasc Interv Radiol. 2014;273(1):241-260. doi:10.1016/j.jvir.2014.08.027
Hegedüs L, Frasoldati A, Negro R, Papini E. European Thyroid Association survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J. 2020;9:194-204. doi:10.1159/000506513
Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound. 2001;13(2):129-147. doi:10.1016/S0929-8266(01)00126-4
De Bernardi IC, Floridi C, Muollo A, et al. Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med. 2014;119(7):512-520. doi:10.1007/s11547-014-0411-2
Shin JH, Baek JH, Ha EJ, Lee JH. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:919650. doi:10.1155/2012/919650
Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011;12(5):525-540. doi:10.3348/kjr.2011.12.5.525
Rhim H, Goldberg SN, Dodd GD, et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21:S17-S35. doi:10.1148/radiographics.21.suppl_1.g01oc11s17
Ha EJ, Baek JH, Lee JH. Moving-shot versus fixed electrode techniques for radiofrequency ablation: comparison in an ex-vivo bovine liver tissue model. Korean J Radiol. 2014;15:836-843. doi:10.3348/kjr.2014.15.6.836
Stafford RJ, Fuentes D, Elliott AA, Weinberg JS, Ahrar K. Laser-induced thermal therapy for tumor ablation. Crit Rev Biomed Eng. 2010;38:79-100. doi:10.1615/CritRevBiomedEng.v38.i1.70
Schena E, Saccomandi P, Fong Y. Laser ablation for cancer: past, present and future. J Funct Biomater. 2017;8:19. doi:10.3390/jfb8020019
Lubner MG, Brace CL, Hinshaw JL, Lee FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21:S192-S203. doi:10.1016/j.jvir.2010.04.007
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25:S69-S83. doi:10.1148/rg.25si055501
Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236:132-139. doi:10.1148/radiol.2361031249
Healey TT, March BT, Baird G, Dupuy DE. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28(2):206-211. doi:10.1016/j.jvir.2016.10.030
Meloni MF, Chiang J, Laeseke PF, et al. Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia. 2017;33:15-24. doi:10.1080/02656736.2016.1209694
Yue W, Wang S, Wang B, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol. 2013;82(1):e11-e16. doi:10.1016/j.ejrad.2012.07.020
Chen X, Wu W, Gong X, Zhou Q, Chen X. Ultrasound-guided percutaneous microwave ablation for solid benign thyroid nodules: comparison of MWA versus control group. Int J Endocrinol. 2017;2017:9724090. doi:10.1155/2017/9724090
Feng B, Liang P, Cheng Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol. 2012;166:1031-1037. doi:10.1530/EJE-11-0966
Wu W, Gong X, Zhou Q, Chen X, Chen X, Shi B. US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules. Endocr J. 2017;64:1079-1085. doi:10.1507/endocrj.EJ17-0152
Liu YJ, Qian LX, Liu D, Zhao JF. Ultrasound-guided microwave ablation in the treatment of benign thyroid nodules in 435 patients. Exp Biol Med. 2017;242:1515-1523. doi:10.1177/1535370217727477
Watson T. Ultrasound in contemporary physiotherapy practice. Ultrasonics. 2008;48:321-329. doi:10.1016/j.ultras.2008.02.004
ter Haar G, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia. 2007;23:89-104. doi:10.1080/02656730601186138
Kotewall N, Lang BHH. High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future. Ultrasonography. 2019;38:135-142. doi:10.14366/usg.18040
ter Haar G. HIFU tissue ablation: concept and devices. Adv Exp Med Biol. 2016;880:3-20. doi:10.1007/978-3-319-22536-4_1
Ryu M, Shimamura Y, Kinoshita T, et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol. 1997;27:251-257. doi:10.1093/jjco/27.4.251
Dimaio CJ, Dewitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas. 2011;40:664-668. doi:10.1097/MPA.0b013e3182128d06
Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253:786-790. doi:10.1097/SLA.0b013e318211ccc2
Bennedbaek FN, Karstrup S, Hegedüs L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol. 1997;136:240-250. doi:10.1530/eje.0.1360240
Karstrup S, Hegedus L, Holm HH. Ultrasonically guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a follow-up study. Clin Endocrinol (Oxf). 1993;38:523-530. doi:10.1111/j.1365-2265.1993.tb00349.x
Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer. 1991;68:1524-1530. doi:10.1002/1097-0142(19911001)68:7<1524::AID-CNCR2820680711>3.0.CO;2-O
Sharma A, Abraham D. Vascularity-targeted percutaneous ethanol injection of toxic thyroid adenomas: outcomes of a feasibility study performed in the USA. Endocr Pract. 2020;26:22-29. doi:10.4158/EP-2019-0329
Morhard R, Nief C, Barrero Castedo C, et al. Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors. Sci Rep. 2017;7:8750. doi:10.1038/s41598-017-09371-2
Ahmed M, Brace CL, Lee FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011;258:351-369. doi:10.1148/radiol.10081634
Tsai WL, Cheng JS, Lai KH, et al. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma-a long-term follow-up study. Aliment Pharmacol Ther. 2008;28:304-311. doi:10.1111/j.1365-2036.2008.03702.x
Yoon HM, Baek JH, Lee JH, et al. Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules. Am J Neuroradiol. 2014;35:582-586. doi:10.3174/ajnr.A3701
Shankar S, VanSonnenberg E, Morrison PR, Tuncali K, Silverman SG. Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation. Am J Roentgenol. 2004;183:1425-1429. doi:10.2214/ajr.183.5.1831425
Shiina S, Sato K, Tateishi R, et al. Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery. Can J Gastroenterol Hepatol. 2018;2018:4756147. doi:10.1155/2018/4756147
Suh CH, Baek JH, Choi YJ, Lee JH. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid. 2016;26(3):420-428. doi:10.1089/thy.2015.0545
Chung SR, Suh CH, Baek JH, Park HS, Choi YJ, Lee JH. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2017;33:1-35. doi:10.1080/02656736.2017.1337936
Dobnig H, Amrein K. Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single-center study. Thyroid. 2018;28:472-480. doi:10.1089/thy.2017.0547
Zhao Q, Tian G, Kong D, Jiang T. Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers. J Endocrinol Invest. 2016;39:909-916. doi:10.1007/s40618-016-0450-8
Jeong SY, Baek JH, Choi YJ, Lee JH. Ethanol and thermal ablation for malignant thyroid tumours. Int J Hyperthermia. 2017;33:938-945. doi:10.1080/02656736.2017.1361048
Dalkey N, Helmer O. An experimental application of the DELPHI method to the use of experts. Manage Sci. 1963;9:351-515. doi:10.1287/mnsc.9.3.458
Dalkey N. The Delphi method: an experimental study of group opinion. Studies in the Quality of Life: Delphi and Decision-Making; Lexington Books; 1972.
Garberoglio R, Aliberti C, Appetecchia M, et al. Radiofrequency ablation for thyroid nodules: Which indications? The first Italian opinion statement. J Ultrasound. 2015;18(4):423-430. doi:10.1007/s40477-015-0169-y
Jenkinson C, Coulter A, Wright L. Short form 36 (SF 36) health survey questionnaire: normative data for adults of working age. Br Med J. 1993;306(6890):1437-1440. doi:10.1136/bmj.306.6890.1437
Watt T, Bjorner JB, Groenvold M, et al. Development of a short version of the thyroid-related patient-reported outcome ThyPRO. Thyroid. 2015;25:1069-1079. doi:10.1089/thy.2015.0209
Bernardi S, Stacul F, Michelli A, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine. 2017;11:317. doi:10.1007/s12020-016-1174-4
Cesareo R, Palermo A, Benvenuto D, et al. Efficacy of radiofrequency ablation in autonomous functioning thyroid nodules. A systematic review and meta-analysis. Rev Endocr Metab Disord. 2019;20:37-44. doi:10.1007/s11154-019-09487-y
Cervelli R, Mazzeo S, Boni G, et al. Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: a retrospective study. Clin Endocrinol (Oxf). 2019;90:608-616. doi:10.1111/cen.13938
Deandrea M, Limone P, Basso E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008;34:784-791. doi:10.1016/j.ultrasmedbio.2007.10.018
Bonnema SJ, Hegedüs L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012;33:920-980. doi:10.1210/er.2012-1030
Cesareo R, Palermo A, Pasqualini V, et al. Radiofrequency ablation on autonomously functioning thyroid nodules: a critical appraisal and review of the literature. Front Endocrinol (Lausanne). 2020;11:317. doi:10.3389/fendo.2020.00317
Lang BHH, Woo YC, Wong IYH, Chiu KWH. Single-session high-intensity focused ultrasound treatment for persistent or relapsed graves disease: preliminary experience in a prospective study. Radiology. 2017;285:1011-1022. doi:10.1148/radiol.2017162776
National Institute for Health and Care Excellence. Ultrasound-Guided Percutaneous Radiofrequency Ablation for Benign Thyroid Nodules. Interventional Procedure Guidance [IPT562]. National Institute for Health and Care Excellence; 2016 https://www.nice.org.uk/
Ruzzenente A, de Manzon G, Molfetta M, et al. Rapid progression of hepatocellular carcinoma after radiofrequency ablation. World J Gastroenterol. 2004;10:1137-1140. doi:10.3748/wjg.v10.i8.1137
Kong J, Kong J, Pan B, et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA. PLoS One. 2012;7:e37266. doi:10.1371/journal.pone.0037266
Kong J, Kong L, Kong J, et al. After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma. J Transl Med. 2012;10:230. doi:10.1186/1479-5876-10-230
Ke S, Ding X, Kong J, et al. Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma. J Transl Med. 2010;8:73. doi:10.1186/1479-5876-8-73
Dobrinja C, Bernardi S, Fabris B, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol. 2015;2015:576576. doi:10.1155/2015/576576
Lim HK, Cho SJ, Baek JH, et al. US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J Radiol. 2019;20:1653-1661. doi:10.3348/kjr.2019.0192
Yan L, Lan Y, Xiao J, Lin L, Jiang B, Luo Y. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2020;31:685-694. doi:10.1007/s00330-020-07128-6
Zhang M, Luo Y, Zhang Y, Tang J. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26:1581-1587. doi:10.1089/thy.2015.0471
Lee SJ, Jung SL, Kim BS, et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol. 2014;15:817-826. doi:10.3348/kjr.2014.15.6.817
Mauri G, Hegedus L, Bandula S, et al. European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10:185-197. doi:10.1159/000516469
Hegedüs L, Miyauchi A, Tuttle RM. Nonsurgical thermal ablation of thyroid nodules: not if, but why, when, and how? Thyroid. 2020;30:1691-1694. doi:10.1089/thy.2020.0659
Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276:909-918. doi:10.1148/radiol.15140079
Gharib H, Hegedüs L, Pacella CM, Baek JH, Papini E. Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98:3949-3957. doi:10.1210/jc.2013-1806
Park HS, Baek JH, Choi YJ, Lee JH. Innovative techniques for image-guided ablation of benign thyroid nodules: combined ethanol and radiofrequency ablation. Korean J Radiol. 2017;18:461-469. doi:10.3348/kjr.2017.18.3.461
Noel JE, Orloff LA. Neck ultrasound: anatomical landmarks for safe performance of neck RFA. Curr Otorhinolaryngol Rep. 2021;9:60-64. doi:10.1007/s40136-020-00316-4
De Bodt MS, Wuyts FL, Van De Heyning PH, Croux C. Test-retest study of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice. 1997;11:74-80. doi:10.1016/S0892-1997(97)80026-4
Eadie TL, Kapsner M, Rosenzweig J, Waugh P, Hillel A, Merati A. The role of experience on judgments of dysphonia. J Voice. 2010;24:564-573. doi:10.1016/j.jvoice.2008.12.005
Chandrasekhar SS, Randolph GW, Seidman MD, et al. Clinical practice guideline: improving voice outcomes after thyroid surgery. Otolaryngol - Head Neck Surg (United States). 2013;148:S1-S37. doi:10.1177/0194599813487301
Arffa RE, Krishna P, Gartner-Schmidt J, Rosen CA. Normative values for the voice handicap index-10. J Voice. 2012;26:462-465. doi:10.1016/j.jvoice.2011.04.006
Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V- RQOL). J Voice. 1999;13:557-569. doi:10.1016/S0892-1997(99)80010-1
Sinclair CF, Bumpous JM, Haugen BR, et al. Laryngeal examination in thyroid and parathyroid surgery: an American Head and Neck Society consensus statement. Head Neck. 2016;38(6):811-819. doi:10.1002/hed.24409
Dossa F, Dubé C, Tinmouth J, et al. Practice recommendations for the use of sedation in routine hospital-based colonoscopy. BMJ Open Gastroenterol. 2020;7:e000348. doi:10.1136/bmjgast-2019-000348
Shaw JR, Kaplovitch E, Douketis J. Periprocedural management of oral anticoagulation. Med Clin North Am. 2020;104:709-726. doi:10.1016/j.mcna.2020.02.005
Hinkelbein J, Lamperti M, Akeson J, et al. European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol. 2018;35:6-24. doi:10.1097/EJA.0000000000000683
Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13:117-125. doi:10.3348/kjr.2012.13.2.117
Kim J, Baek JH, Lim HK, Na DG. Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline. Ultrasonography. 2019;38:125-134. doi:10.14366/usg.18044
Park HS, Baek JH, Park AW, Chung SR, Choi YJ, Lee JH. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18:615-623. doi:10.3348/kjr.2017.18.4.615
Gitman M, Fettiplace MR, Weinberg GL, Neal JM, Barrington MJ. Local anesthetic systemic toxicity: a narrative literature review and clinical update on prevention, diagnosis, and management. Plast Reconstr Surg. 2019;144:783-795. doi:10.1097/PRS.0000000000005989
Neal JM, Barrington MJ, Fettiplace MR, et al. The Third American Society of Regional Anesthesia and Pain Medicine practice advisory on local anesthetic systemic toxicity: executive summary 2017. Reg Anesth Pain Med. 2018;43:113-123. doi:10.1097/AAP.0000000000000720
Laeseke PF, Sampson LA, Brace CL, Winter TC, Fine JP, Lee FT. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. Am J Roentgenol. 2006;186:S249-S254. doi:10.2214/AJR.04.1240
Laeseke PF, Sampson LA, Winter TC, Lee FT. Use of dextrose 5% in water instead of saline to protect against inadvertent radiofrequency injuries. Am J Roentgenol. 2005;184:1026-1027. doi:10.2214/ajr.184.3.01841026
Bernardi S, Lanzilotti V, Papa G, et al. Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule. Thyroid. 2016;26:183-184. doi:10.1089/thy.2015.0453
Huh JY, Baek JH, Choi H, Kim JK, Lee JH. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session-prospective randomized study. Radiology. 2012;263:909-916. doi:10.1148/radiol.12111300
Ahn HS, Kim SJ, Park SH, Seo M. Radiofrequency ablation of benign thyroid nodules: evaluation of the treatment efficacy using ultrasonography. Ultrasonography. 2016;35:244-252. doi:10.14366/usg.15083
Ha EJ, Baek JH, Lee JH. Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol. 2015;16:749-766. doi:10.3348/kjr.2015.16.4.749
Offi C, Garberoglio S, Antonelli G, et al. The ablation of thyroid nodule's afferent arteries before radiofrequency ablation: preliminary data. Front Endocrinol (Lausanne). 2021;11:565000. doi:10.3389/fendo.2020.565000
Zhao CK, Xu HX, Lu F, et al. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: first results of CEUS evaluation. Clin Hemorheol Microcirc. 2017;65:393-405. doi:10.3233/CH-16208
Kim HJ, Cho SJ, Baek JH, Suh CH. Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2020;31:605-615. doi:10.1007/s00330-020-07166-0
Lim HK, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015;25:163-170. doi:10.1007/s00330-014-3405-5
Xiaoyin T, Ping L, Dan C, et al. Risk assessment and hydrodissection technique for radiofrequency ablation of thyroid benign nodules. J Cancer. 2018;9:3058-3066. doi:10.7150/jca.26060
Lee J, Shin JH, Hahn SY, Park KW, Choi JS. Feasibility of adjustable electrodes for radiofrequency ablation of benign thyroid nodules. Korean J Radiol. 2020;21:377-383. doi:10.3348/kjr.2019.0724
Turtulici G, Orlandi D, Corazza A, et al. Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol. 2014;40:1447-1452. doi:10.1016/j.ultrasmedbio.2014.02.017
Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000;217:673-677. doi:10.1148/radiology.217.3.r00dc09673
Døssing H, Bennedbaek FN, Hegedüs L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules-a randomised study. Eur J Endocrinol. 2005;152:341-345. doi:10.1530/eje.1.01865
Døssing H, Bennedbaek FN, Hegedüs L. Beneficial effect of combined aspiration and interstitial laser therapy in patients with benign cystic thyroid nodules: a pilot study. Br J Radiol. 2006;79:943-947. doi:10.1259/bjr/40698061
Pacella CM, Bizzari G, Spiezia S, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;232:272-280. doi:10.1148/radiol.2321021368
Yue WW, Wang SR, Lu F, et al. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study. Endocrine. 2017;55:485-495. doi:10.1007/s12020-016-1173-5
Cheng Z, Che Y, Yu S, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci Rep. 2017;7:9554. doi:10.1038/s41598-017-09930-7
Heck K, Happel C, Grünwald F, Korkusuz H. Percutaneous microwave ablation of thyroid nodules: effects on thyroid function and antibodies. Int J Hyperthermia. 2015;31:560-567. doi:10.3109/02656736.2015.1032371
Korkusuz H, Happel C, Koch DA, Gruenwald F. Combination of ultrasound-guided percutaneous microwave ablation and radioiodine therapy in benign thyroid disease: a 3-month follow-up study. RoFo. 2016;188:60-68. doi:10.1055/s-0041-106538
Wang B, Han ZY, Yu J, et al. Factors related to recurrence of the benign non-functioning thyroid nodules after percutaneous microwave ablation. Int J Hyperthermia. 2017;33:459-464. doi:10.1080/02656736.2016.1274058
Palyga I, Palyga R, Mlynarczyk J, Kopczynski J, Gózdz S, Kowalska A. The current state and future perspectives of high intensity focused ultrasound (HIFU) ablation for benign thyroid nodules. Gland Surg. 2020;9:S95-S104. doi:10.21037/gs.2019.10.16
Lang BH, Wu ALH. The efficacy and safety of high-intensity focused ultrasound ablation of benign thyroid nodules. Ultrasonography. 2018;61:1636-1643. doi:10.14366/usg.17057
Korkusuz H, Fehre N, Sennert M, Happel C, Grünwald F. Volume reduction of benign thyroid nodules 3 months after a single treatment with high-intensity focused ultrasound (HIFU). J Ther Ultrasound. 2015;3:4. doi:10.1186/s40349-015-0024-9
Kovatcheva RD, Vlahov JD, Stoinov JI, Zaletel K. Benign solid thyroid nodules: US-guided high-intensity focused ultrasound ablation-initial clinical outcomes. Radiology. 2015;276:597-605. doi:10.1148/radiol.15141492
Kim YJ, Baek JH, Ha EJ, et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol. 2012;22:1573-1578. doi:10.1007/s00330-012-2406-5
Sung JY, Kim YS, Choi H, Lee JH, Baek JH. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? Am J Roentgenol. 2011;196:W210-W214. doi:10.2214/AJR.10.5172
Ko ES, Sung JY, Shin JH. Intralesional saline injection for effective ultrasound-guided aspiration of benign viscous cystic thyroid nodules. Ultrasonography. 2014;33:122-127. doi:10.14366/usg.13027
Yasuda K, Ozaki O, Sugino K, et al. Treatment of cystic lesions of the thyroid by ethanol instillation. World J Surg. 1992;16:958-961. doi:10.1007/BF02067001
Baek JH, Kim YS, Sung JY, Choi H, Lee JH. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol. 2011;197:W331-W336. doi:10.2214/AJR.10.5345
Verde G, Papini E, Pacella CM, et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf). 1994;41:719-724. doi:10.1111/j.1365-2265.1994.tb02785.x
Monzani F, Lippi F, Goletti O, et al. Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts. J Clin Endocrinol Metab. 1994;78(3):800-802. doi:10.1210/jc.78.3.800
Zingrillo M, Torlontano M, Ghiggi MR, et al. Percutaneous ethanol injection of large thyroid cystic nodules. Thyroid. 1996;6:403-408. doi:10.1089/thy.1996.6.403
Kim DW, Rho MH, Kim HJ, Kwon JS, Sung YS, Lee SW. Percutaneous ethanol injection for benign cystic thyroid nodules: is aspiration of ethanol-mixed fluid advantageous? Am J Neuroradiol. 2005;26:2122-2127.
Park HS, Yim Y, Baek JH, Choi YJ, Shong YK, Lee JH. Ethanol ablation as a treatment strategy for benign cystic thyroid nodules: a comparison of the ethanol retention and aspiration techniques. Ultrasonography. 2019;38:166-171. doi:10.14366/usg.18033
Sung JY, Baek JH, Kim KS, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology. 2013;269:293-300. doi:10.1148/radiol.13122134
Guenette JP, Monchik JM, Dupuy DE. Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol. 2013;24:672-679. doi:10.1016/j.jvir.2013.02.001
Kim BM, Kim MJ, Kim EK, Il PS, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol. 2008;18:835-842. doi:10.1007/s00330-007-0809-5
Heilo A, Sigstad E, Fagerlid KH, et al. Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab. 2011;96:2750-2755. doi:10.1210/jc.2010-2952
Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol. 2002;178:699-704. doi:10.2214/ajr.178.3.1780699
Chi YL, Yun JS, Lee J, Nam KH, Woong YC, Cheong SP. Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid. 2007;17:347-350. doi:10.1089/thy.2006.0251
Carneiro-Pla D, Miller BS, Wilhelm SM, et al. Feasibility of surgeon-performed transcutaneous vocal cord ultrasonography in identifying vocal cord mobility: a multi-institutional experience. Surgery. 2014;156(6):1597-1604. doi:10.1016/j.surg.2014.08.071
Kandil E, Deniwar A, Noureldine SI, et al. Assessment of vocal fold function using transcutaneous laryngeal ultrasonography and flexible laryngoscopy. JAMA Otolaryngol Head Neck Surg. 2016;142:74-78. doi:10.1001/jamaoto.2015.2795
Spiezia S, Garberoglio R, Milone F, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid. 2009;19:219-225. doi:10.1089/thy.2008.0202
Sim JS, Baek JH, Lee J, Cho W, Il JS. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int J Hyperthermia. 2017;33:905-910. doi:10.1080/02656736.2017.1309083
Bernardi S, Giudici F, Cesareo R, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally invasive treatments of the thyroid group. Thyroid. 2020;30:1759-1770. doi:10.1089/thy.2020.0202
Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244-1250. doi:10.1007/s00330-008-0880-6
Baek JH, Moon WJ, Kim YS, Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg. 2009;33:1971-1977. doi:10.1007/s00268-009-0130-3
Ha SM, Shin JY, Baek JH, et al. Does radiofrequency ablation induce neoplastic changes in benign thyroid nodules: a preliminary study. Endocrinol Metab. 2019;34:169-178. doi:10.3803/EnM.2019.34.2.169
Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64:316-321. doi:10.1007/s12020-018-1829-4
Özden S, Er S, Tez M. Letter to “Successful radiofrequency ablation strategies for benign thyroid nodules”. Endocrine. 2019;64:316-321. doi:10.1007/s12020-019-01879-z
Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015;21:887-896. doi:10.4158/EP15676.OR
Pace-Asciak P, Russell JO, Shaear M, Tufano RP. Novel approaches for treating autonomously functioning thyroid nodules. Front Endocrinol (Lausanne). 2020;11:565371. doi:10.3389/fendo.2020.565371
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L. Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum TSH. J Clin Endocrinol Metab. 2017;102:2301-2309. doi:10.1210/jc.2017-00166
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L. Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol. 2019;180:407-416. doi:10.1530/EJE-19-0006
Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26:150-155. doi:10.1089/thy.2015.0313
Valcavi R, Piana S, Bortolan GS, Lai R, Barbieri V, Negro R. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013;23:1578-1582. doi:10.1089/thy.2013.0279
Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review. Thyroid. 2018;28:1134-1142. doi:10.1089/thy.2017.0558
Xu D, Ge M, Yang A, et al. Expert consensus workshop report: guidelines for thermal ablation of thyroid tumors (2019 edition). J Cancer Res Ther. 2020;16:960-966. doi:10.4103/jcrt.JCRT_558_19
Cho SJ, Baek JH, Chung SR, Choi YJ, Lee JH. Long-term results of thermal ablation of benign thyroid nodules: a systematic review and meta-analysis. Endocrinol Metab. 2020;35:339-350. doi:10.3803/EnM.2020.35.2.339
Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. Am J Neuroradiol. 2015;36(7):1321-1325. doi:10.3174/ajnr.A4276
Bernardi S, Dobrinja C, Fabris B, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595. doi:10.1155/2014/934595
Yue WW, Li XL, Xu HX, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep. 2016;6:37838. doi:10.1038/srep37838
Bernardi S, Dobrinja C, Carere A, et al. Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey. Int J Hyperthermia. 2018;35:150-158. doi:10.1080/02656736.2018.1487590
Shin JE, Baek JH, Lee JH. Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol. 2013;25(1):14-19. doi:10.1097/CCO.0b013e32835a583d
Chung SR, Baek JH, Choi YJ, Lee JH. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Eur Radiol. 2019;29:4897-4903. doi:10.1007/s00330-019-06063-5
Wu R, Luo Y, Tang J, et al. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia. 2020;37:168-174. doi:10.1080/02656736.2019.1708480
Cho SJ, Baek SM, Lim HK, Lee KD, Son JM, Baek JH. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30:1745-1751. doi:10.1089/thy.2020.0106
Døssing H, Bennedbaek FN, Karstrup S, Hegedüs L. Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation-initial experience. Radiology. 2002;225:53-57. doi:10.1148/radiol.2251011042
Døssing H, Bennedbaek FN, Hegedüs L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol. 2011;165:123-128. doi:10.1530/EJE-11-0220
Achille G, Zizzi S, Di Stasio E, Grammatica A, Grammatica L. Ultrasound-guided percutaneous laser ablation in treating symptomatic solid benign thyroid nodules: our experience in 45 patients. Head Neck. 2016;38(5):677-682. doi:10.1002/hed.23957
Papini E, Rago T, Gambelunghe G, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014;99:3653-3659. doi:10.1210/jc.2014-1826
Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid. 2010;20:1253-1261. doi:10.1089/thy.2010.0189
Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100:3903-3910. doi:10.1210/jc.2015-1964
Døssing H, Bennedbaek FN, Bonnema SJ, Grupe P, Hegedüs L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007;157:95-100. doi:10.1530/EJE-07-0094
Pacella CM, Mauri G. Is there a role for minimally invasive thermal ablations in the treatment of autonomously functioning thyroid nodules? Int J Hyperthermia. 2018;34:636-638. doi:10.1080/02656736.2018.1462537
Zhou W, Ni X, Xu S, Zhang L, Chen Y, Zhan W. Ultrasound-guided laser ablation versus surgery for solitary papillary thyroid microcarcinoma: a retrospective study. Int J Hyperthermia. 2019;36:897-904. doi:10.1080/02656736.2019.1649475
Tong M, Li S, Li Y, Li Y, Feng Y, Che Y. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36:1278-1286. doi:10.1080/02656736.2019.1700559
Morelli F, Sacrini A, Pompili G, et al. Microwave ablation for thyroid nodules: a new string to the bow for percutaneous treatments? Gland Surg. 2016;5:553-558. doi:10.21037/gs.2016.12.07
Zheng BW, Wang JF, Ju JX, Wu T, Tong G, Ren J. Efficacy and safety of cooled and uncooled microwave ablation for the treatment of benign thyroid nodules: a systematic review and meta-analysis. Endocrine. 2018;62:307-317. doi:10.1007/s12020-018-1693-2
Jin H, Fan J, Liao K, He Z, Li W, Cui M. A propensity score matching study between ultrasound-guided percutaneous microwave ablation and conventional thyroidectomy for benign thyroid nodules treatment. Int J Hyperthermia. 2018;35:232-238. doi:10.1080/02656736.2018.1492028
Zhi X, Zhao N, Liu Y, Bin LJ, Teng C, Qian L. Microwave ablation compared to thyroidectomy to treat benign thyroid nodules. Int J Hyperthermia. 2018;34:644-652. doi:10.1080/02656736.2018.1456677
Yan J, Qiu T, Lu J, Wu Y, Yang Y. Microwave ablation induces a lower systemic stress response in patients than open surgery for treatment of benign thyroid nodules. Int J Hyperthermia. 2018;34:606-610. doi:10.1080/02656736.2018.1427286
Lang BHH, Wu ALH. High intensity focused ultrasound (HIFU) ablation of benign thyroid nodules-a systematic review. J Ther Ultrasound. 2017;5:11. doi:10.1186/s40349-017-0091-1
Monpeyssen H, Ben Hamou A, Hegedüs L, et al. High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules: a 3-year retrospective multicenter follow-up study. Int J Hyperthermia. 2020;37:1301-1309. doi:10.1080/02656736.2020.1846795
Sennert M, Happel C, Korkusuz Y, Grünwald F, Polenz B, Gröner D. Further investigation on high-intensity focused ultrasound (HIFU) treatment for thyroid nodules: effectiveness related to baseline volumes. Acad Radiol. 2018;25:88-94. doi:10.1016/j.acra.2017.07.011
Lang BHH, Woo YC, Chiu KWH. Single-session high-intensity focused ultrasound treatment in large-sized benign thyroid nodules. Thyroid. 2017;27:714-721. doi:10.1089/thy.2016.0664
Lang BHH, Wong CKH, Ma EPM. Single-session high intensity focussed ablation (HIFU) versus open cervical hemithyroidectomy for benign thyroid nodule: analysis on early efficacy, safety and voice quality. Int J Hyperthermia. 2017;33:868-874. doi:10.1080/02656736.2017.1305127
Giovanella L, Piccardo A, Pezzoli C, et al. Comparison of high intensity focused ultrasound and radioiodine for treating toxic thyroid nodules. Clin Endocrinol (Oxf). 2018;89:219-225. doi:10.1111/cen.13738
Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American college of endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update. Endocr Pract. 2016;22:622-639. doi:10.4158/EP161208.GL
Bennedbaek FN, Hegedüs L. Percutaneous ethanol injection therapy in benign solitary solid cold thyroid nodules: a randomized trial comparing one injection with three injections. Thyroid. 1999;9:225-233. doi:10.1089/thy.1999.9.225
Ferreira MC, Piaia C, Cadore AC. Percutaneous ethanol injection versus conservative treatment for benign cystic and mixed thyroid nodules. Arch Endocrinol Metab. 2016;60:211-216. doi:10.1590/2359-3997000000120
Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract. 2004;10:269-275. doi:10.4158/EP.10.3.269
Kim SY, Kim SM, Chang H, et al. Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer. Eur Arch Oto-Rhino-Laryngology. 2017;274:3497-3501. doi:10.1007/s00405-017-4660-2
Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surg (United States). 2013;154:1448-1454. doi:10.1016/j.surg.2013.07.007
Deandrea M, Garino F, Alberto M, et al. Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study. Eur J Endocrinol. 2019;180:79-87. doi:10.1530/EJE-18-0685
Chung SR, Baek JH, Choi YJ, Lee JH. Management strategy for nerve damage during radiofrequency ablation of thyroid nodules. Int J Hyperthermia. 2019;36:204-210. doi:10.1080/02656736.2018.1554826
Wu Y, Jia JP, Xu M, et al. Role of nitric oxide in pathogenesis of cold nerve injury. Natl Med J China. 2009;89:2214-2220. doi:10.3760/cma.j.issn.0376-2491.2009.31.015
Esposito RA, Spencer FC. The effect of pericardial insulation on hypothermic phrenic nerve injury during open-heart surgery. Ann Thorac Surg. 1987;43:303-308. doi:10.1016/S0003-4975(10)60619-4
Chung SR, Baek JH, Sung JY, Ryu JH, Jung SL. Revisiting rupture of benign thyroid nodules after radiofrequency ablation: various types and imaging features. Endocrinol Metab. 2019;34:415-421. doi:10.3803/EnM.2019.34.4.415
Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with us-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262:335-342. doi:10.1148/radiol.11110416
Shin JH, Jung SL, Baek JH, Kim JH. Rupture of benign thyroid tumors after radio-frequency ablation. Am J Neuroradiol. 2011;32:2165-2169. doi:10.3174/ajnr.A2661
van Baardewijk LJ, Plaisier ML, van den Broek FJC, van Poppel PCMW, Kurban S, Kruimer JWH. Tracheal necrosis following radiofrequency ablation of a benign thyroid nodule. Cardiovasc Intervent Radiol. 2021;44(1):170-171. doi:10.1007/s00270-020-02632-0
Kumar A, Kugler J, Jensen T. Evaluation of trainee competency with point-of-care ultrasonography (POCUS): a conceptual framework and review of existing assessments. J Gen Intern Med. 2019;34:1025-1031. doi:10.1007/s11606-019-04945-4
Martín-Hernández T, Díez Gómez JJ, Díaz-Soto G, et al. Consensus statement for use and technical requirements of thyroid ultrasound in endocrinology units. Endocrinol Diabet Nutr. 2017;64:23-30. doi:10.1016/j.endinu.2016.10.007